Khiron Life Sciences Corp (KHRNF)

[happyglass]

I agree

[Nosnibor]

Khiron is probably the most under-estimated / appreciated / valued MJ play out there. Bold statement from an investor who has in fact invested in multi multi MJ companies in recent years. I predict big things (and returns). Long and strong (for real).

[happyglass]

I am glad to see another country opening up!
https://www.instagram.com/tv/CRCZDEZH-8f/?utm_medium=copy_link

[nowwhat2]

The Great Khiron Death Nail (and all that surrounds it).....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164757947

[BudGuy]

Dropped .06 as expected if math serves w value of warrants etc

Expansion in Mexico?

[jp68]

My guess this will be used for rapid expansion.
Khiron Life Sciences Announces Terms of Overnight Marketed Offering

https://money.tmx.com/en/quote/KHRNF:US/news/6660095763378777/Khiron_Life_Sciences_Announces_Terms_of_Overnight_Marketed_Offering

[nowwhat2]

Sorry gang.....Must be some news out huh ?




Can't say U were not warned 10 sessions beforehand

[MoneyForNuthin]

$KHRNF Awesome news - continuing to move rapidly forward!

[BudGuy]

https://investors.khiron.ca/investor-information/news-events/press-releases/detail/222/khiron-successfully-completes-first-medical-cannabis-sale

[jsnhgns]

https://www.marijuanamoment.net/mexicos-supreme-court-strikes-down-marijuana-prohibition-after-lawmakers-fail-to-act/

[happyglass]

Excellent news! I know they are in place and ready to act as soon as they are able to, Legally

[BudGuy]

https://www.prnewswire.com/news-releases/khiron-accelerates-entry-into-mexico-awarded-high-thc-extract-export-quotas-for-mexico-by-the-government-of-colombia-301320951.html

[jsnhgns]

https://www.marijuanamoment.net/mexicos-supreme-court-moves-to-end-marijuana-prohibition-itself-after-lawmakers-fail-to-act/ Vote on Monday.

[happyglass]

I think this bodes well for Khiron. Mexico seems to be taking the same path Canada did, the courts initiated here too before the legislators managed to do anything

https://marijuanamoment.us14.list-manage.com/track/click?u=2b103be7b5d7ad4abd40bfebc&id=0d6dd42afa&e=85a0fd8134

[BudGuy]

More volume

[BudGuy]

Late volume today

[nowwhat2]

Same as :




Same as :




Same as :

https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=&symb=ca%3Acweb&x=0&y=0&time=100&startdate=4%2F1%2F2020&enddate=7%2F23%2F2021&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=none&ma=1&maval=50+200&uf=0&lf=1&lf2=0&lf3=0&type=2&style=320&size=3&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11

[happyglass]

Companies in California face many hurdles that companies outside the US do not have to deal with
This is why the global market is more likely to thrive near term possibly forever depending how long it takes for the US to get out of its own way.
California as the 5th largest economy implies it is cohesive. It is not. More local jurisdictions ban cannabis than allow it.
Meanwhile Khiron is being accommodated and actively assisted by the countries they are expanding into.
https://www.latimes.com/california/story/2021-06-14/california-struggling-marijuana-industry-cash-grants-budget

[happyglass]

[happyglass]

Are they growing premium bud a scale and selling for a high price? If so, they have a chance. If they play their cards right, their 6 million square feet will supply much of the US when they allow interstate commerce. That will leave the rest of the MSOs with redundant grow space they have to unload just like the LPs in Canada. Once the listing settles down and all the early money guys take their profits it might be worth a look. The fact they are in California is a bonus. The 5th largest economy in the world will keep their lights on while the rest of the country gets its act together. It looks like a much better deal than many I have seen.
Weed has proven to be extremely difficult to grow at scale. Any stress can cause hermies then there is powdery mildew and pests. If they can do it they will be very successful. I hope it does well for you. Thank you for mentioning it, I will put it on watch :)

[steadykickin]

I had to read that bit of humor again.....so funny. You're full of shit.

[Etailer]

Have you ever heard of Glass House Group one of the largest growers in California? they merged with Mercer Park and have over 500,000Ft of canopy. The Founder of Ayer Welness is also the founder of Mercer Park and we all know how that SPAC turned out.


Mercer Park Brand Acquisition Corp. and Glass House Group Announce Business Combination to Create the Largest Cannabis Brand-Building Platform in California

Combination Creates the Most Expansive, Fully Integrated Cannabis Business in the World’s Largest Cannabis Market
Long-term Cultivation Expansion to 6 Million ft2 of State-of-the-Art Greenhouse Represents by Far the Largest Capacity of Any Cannabis Operator in California

Retail Footprint Expected to Reach 21 Operational Dispensaries by Q1 2022, More Than Double the Next Largest Retail Operator
Current Brand Portfolio Includes Glass House Farms – the #2 Ranked Flower Brand in California (YE2020 per BDS Analytics), as well as Forbidden Flowers and Mama Sue

Total Purchase Price Consideration of US$567 Million Represents a 2022E Revenue and Adjusted EBITDA Multiple of 1.7x and 5.5x, Respectively
Investors Commit to US$85 Million Private Placement; Combined Public Company Expected to Have up to $US355 Cash Balance at Closing

[steadykickin]

It's your story.

[happyglass]

I do not like SPACs at all. As I understand them the retail investors get the privilege of guaranteeing the rich guy’s returns on his investment. If they do not deploy the money the rich guys get their original investment back. As a retailer the only thing I see as a possible benefit is maybe the SPAC bringing a good private company into the public realm. Anybody that has a reason that SPACs are anything positive for retail I would love to hear it.

[happyglass]

The stock market is nuanced. I have done very well being illogical :) I go with what works. Go where the market will be, not where it is……. Kind of Gretzkyesque. There are no algos for that.

[Etailer]

Mercer Park Brand Acquisition Corp
MRCQF

Definitely under the radar for most, it’s a newly listed SPAC.
You may want to listen or read this podcast.

https://seekingalpha.com/article/4434649-consolidating-california-cannabis-podcast-transcript?mail_subject=mrcqf-consolidating-california-cannabis-podcast-transcript&utm_campaign=rta-stock-article&utm_content=link-2&utm_medium=email&utm_source=seeking_alpha#comments

CRLBF CURLF GRAMF GTBIF HRVSF JUSHF NXGWF MRCQF PLNHF RWBYF TCNNF VRNOF

[steadykickin]

Mercer Park....which is That?

[Etailer]

Those tickers are all of my Cannabis holdings. Lately I have been moving into the top California consolidators. The Parent Company and Mercer Park are my newest stocks.

CRLBF CURLF GRAMF GTBIF HRVSF JUSHF NXGWF MRCQF PLNHF RWBYF TCNNF VRNOF

[steadykickin]

Personally, I have done well going "Long" on three of those ticker symbols. Timing is everthing obviously.

[steadykickin]

"Logic" is not his/her strong suit. Plain and simple.

[happyglass]

Zerenia has now opened in Peru :) This is an MCO :) Multi Country Operator

https://markets.qtrade.ca/stocks/overview?t=iKXJizM-dSY,RBgdWBB-F545YOYG85GxjQk93YnLKQj0&symbol=CA:KHRN&rtl2=0&agreementVer=1&agreementDate=04/04/2017&status=N&sma=0&lang=en#

Dow Jones
Khiron Opens First Zerenia(TM) Clinic in Peru, Prescribing High and Low THC Medical Cannabis Products to Patients
06/10/2021 09:00 AM ET
-- Company launches first Zerenia(TM) medical cannabis clinic outside of
Colombia, exporting proven clinic model via strategic partnership with
Lima-based Clinica Montesur

-- Clinica Montesur is a specialized medical clinic with over 90 doctors
covering 19 specialties and 11,000 patient transactions annually; its
clinic is centrally located in Lima, Peru, a city of 10 million people or
a third of the country's total population

-- Partnership combines Khiron's unique medical cannabis expertise,
including the Company's real-world evidence, medical education, best
practices and systems, with Clinica Montesur's patient base, clinical
infrastructure and medical staff

-- In Q1 2021, Khiron's medical cannabis sales in Peru increased by over
175% compared to total sales in 2020

-- Zerenia(TM) is the category leader in medical cannabis sales in Colombia,
with over 20,000 filled prescriptions and over 8,000 individual patients
to date, 50% patient retention, and average 90% gross margins

-- The new Zerenia location brings Khiron's total clinic count to 11 across
Latin America
TORONTO, June 10, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announces the launch of its first Zerenia(TM) clinic outside of Colombia, in Lima, Peru. Following the success of the Company's clinic strategy in Colombia, the new clinic has been established as a strategic partnership between Khiron and Clinica Montesur, a specialized medical provider in Lima with over 90 physicians and more than 11,000 patient transactions annually.
Lima
Alvaro Torres, CEO and Director comments, "I am pleased to announce the first expansion of our Zerenia brand beyond Colombia. Knowing that prescription rates at our Zerenia clinics are 14 times higher than those of our external clinic partners, we are excited to bring a proven marketing, sales, and distribution model to a market of over ten million people. To date, our Zerenia clinics have played a vital role in not only introducing patients to Khiron products, but also in developing an exceptional patient experience and growing base of returning patients. As we continue to develop our unique, service-oriented platform, we are proud to introduce Zerenia to the Peruvian market, where initial reception to our products has been strong since sales began late last year."
With over 30 years of experience in Peru, Clinica Montesur is dedicated to high quality care across 19 areas of specialization, including oncology, dermatology, ophthalmology, and psychology. As part of the strategic partnership, Clinica Montesur will provide clinic infrastructure, including its medical facility, clinic permits, systems, and medical staff, among others. The partnership will leverage Khiron's unique Zerenia(TM) medical cannabis model, including the Company's medical cannabis education platform, real-world evidence, and standard operating procedures. Patients of the clinic will be able to fill prescriptions for High THC and Low THC (CBD) medical cannabis at ten Farmacia Universal S.A.C. locations throughout Lima, as previously announced by the Company.

[happyglass]

There is a difference between trading and investing. I am invested in Khiron as long as they continue progressing. With the demise of the US dollar as the main world currency it make sense to diversify to global assets

[Etailer]

Yeah and we all know Ted Ohashi's track record. One could have made a crapload of money shorting all of his recommendations a few years ago.

CRLBF CURLF GRAMF GTBIF HRVSF JUSHF NXGWF PLNHF RWBYF TCNNF VRNOF

[happyglass]

How does a 40,000 share buy drop the price 2cents?

[happyglass]

The patient base will get much larger soon. Scientists are finally able to study this plant and what they are finding is amazing. No surprise to anyone who had to dodge the law to get the relief the plant gives them.
I particularly like this line......... “ Recently, in vitro and in vivo evidence support the effectiveness of phytocannabinoids against various cancer types”

https://www.mdpi.com/1420-3049/26/9/2668

Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?

by Ersilia Nigro 1,2OrcID, Marialuisa Formato 1OrcID, Giuseppina Crescente 1 and Aurora Daniele 1,2,*OrcID
1
Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Università della Campania “Luigi Vanvitelli”, Via G. Vivaldi 42, 81100 Caserta, Italy
2
CEINGE-Biotecnologie Avanzate, Via G. Salvatore 486, 80145 Napoli, Italy
*
Author to whom correspondence should be addressed.
Academic Editors: Bruno Botta and Francesco Paolo Busardò
Molecules 2021, 26(9), 2668; https://doi.org/10.3390/molecules26092668
Received: 14 March 2021 / Revised: 21 April 2021 / Accepted: 30 April 2021 / Published: 2 May 2021
(This article belongs to the Special Issue Industrial Hemp Chemistry and Nutraceutical Perspectives)
View Full-Text Download PDF Browse Figures Citation Export
Abstract
Cannabis sativa L. is a source of over 150 active compounds known as phytocannabinoids that are receiving renewed interest due to their diverse pharmacologic activities. Indeed, phytocannabinoids mimic the endogenous bioactive endocannabinoids effects through activation of CB1 and CB2 receptors widely described in the central nervous system and peripheral tissues. All phytocannabinoids have been studied for their protective actions towards different biological mechanisms, including inflammation, immune response, oxidative stress that, altogether, result in an inhibitory activity against the carcinogenesis. The role of the endocannabinoid system is not yet completely clear in cancer, but several studies indicate that cannabinoid receptors and endogenous ligands are overexpressed in different tumor tissues. Recently, in vitro and in vivo evidence support the effectiveness of phytocannabinoids against various cancer types, in terms of proliferation, metastasis, and angiogenesis, actions partially due to their ability to regulate signaling pathways critical for cell growth and survival. The aim of this review was to report the current knowledge about the action of phytocannabinoids from Cannabis sativa L. against cancer initiation and progression with a specific regard to brain, breast, colorectal, and lung cancer as well as their possible use in the therapies. We will also report the known molecular mechanisms responsible for such positive effects. Finally, we will describe the actual therapeutic options for Cannabis sativa L. and the ongoing clinical trials. View Full-Text
Keywords: Cannabis sativa L.; phytocannabinoids; inflammation; cancer therapeutic agents
? Show Figures

[john1311]

Khiron's largest shipment to date of EU-GMP certified medical cannabis product arrives in Germany

Khiron 20/1, a THC-dominant Cannabis flower, becomes second Khiron-branded product to launch in Germany, having been prescribed in the UK
36.6kg shipment expected to have positive impact on Q2 2021 medical cannabis sales in Europe

German medical cannabis market positioned for significant growth with national insurance coverage and an estimated patient base of over 100,000

https://investors.khiron.ca/investor-information/news-events/press-releases/detail/217/khiron-receives-its-largest-european-medical-cannabis

[olivernoyes]

Thanks, I will check it out.

[olivernoyes]

thanks for the link happyglass!

[happyglass]

The link for the Benzinga Cannabis conference.

Good info
Khiron starts at around 4:23:00

[happyglass]

Thank you very much

[Troytex]

Time about 1 pm…plus another spot about 1 55pm
Alvaro Torres
CEO@Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (FRA: A2JMZC)
Mr. Torres has over 15 years of experience in the Latin American market, including infrastructure projects and project finance, management strategy, team development, and mergers and acquisitions. Mr. Torres was previously head of business development for SNC-Lavalin, Colombia, and was instrumental in growing the company from two people to more than 2,000 people in Colombia over the course of three years. Mr. Torres has overseen the development of projects totaling over $1 billion in capital expenditure, including the development and construction of Colombia’s tallest skyscraper. Mr. Torres holds a Bachelor of Engineering and a Masters of Engineering from Rensselaer Polytechnic Institute and an MBA from Georgetown University.

[Nosnibor]

No doubt whatsoever Khiron will continue to grow as a major player.

[happyglass]

Ted Ohashi still sees Khiron as a player and so do I.

[happyglass]

Khiron to present at the Benzinga Cannabis Conference

Dow Jones
Khiron Life Sciences Corp.: Invitation to the Benzinga Virtual Cannabis Capital Conference
06/01/2021 08:01 AM ET
Detroit, Michigan--(Newsfile Corp. - June 1, 2021) - Khiron Life Sciences Corp. (TSXV: KHRN) will be presenting at the Benzinga Cannabis Capital Conference taking place on June 3-4, 2021. We invite our shareholder and all interested parties to join us for a full day of networking, dealmaking and discovery. Sign up to get a free spectator pass for the event: https://events.benzinga.com/ccc-free-registration
About Benzinga Cannabis Capital Conference
Benzinga's virtual Cannabis Capital Conference is guaranteed to offer participants all the benefits of an immersive and robust in-person conference from any remote location. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space. Don't miss this opportunity to connect with THE cannabis movers and shakers from across the globe.
For more information and/or to register for the conference please visit: https://events.benzinga.com/ccc-free-registration
We look forward to seeing you there.
For further information:
Khiron Life Sciences Corp.
Paola Ricardo
416-540-2970
[e-mail]
https://investors.khiron.ca/corporate-information
(END) Dow Jones Newswires
June 01, 2021 08:01 ET (12:01 GMT)

[happyglass]

Mexican Supreme Court is not waiting for congress! They are annulling the laws unilaterally. Big step forward for Khiron
Avalará Corte cannabis ante omisión de Congreso
Víctor Fuentes
Cd. de México (27 mayo 2021).-
05:00 hrs
Ante los retrasos e incumplimiento del Congreso para legalizar y regular el consumo recreativo de la cannabis, la Corte se prepara para anular cinco artículos de la Ley General de Salud (LGS) que prohíben ese estupefaciente.

Cannabis Court will endorse before Congress omission
Victor Fuentes
Mexico City (May 27, 2021) .-
05:00 hrs
Given the delays and failure of Congress to legalize and regulate the recreational use of cannabis, the Court is preparing to annul five articles of the General Health Law (LGS) that prohibit this drug.






https://www.reforma.com/aplicacioneslibre/preacceso/articulo/default.aspx?urlredirect=https://www.reforma.com/avalara-corte-cannabis-ante-omision-de-congreso/ar2191169?__rval=1

[BudGuy]

Light it up!!

[john1311]

Record revenues of $2.8 million in Q1 2021, a 49% increase from the prior year and 13% increase from Q4 2020

Record gross profits (before fair market value adjustments) of $1.1 million, a 171% improvement over Q4 2020 and record consolidated gross margin of 38%

[happyglass]

Khiron innovating and helping cancer patients while educating doctors about the effectiveness of this medicine. No better proof than what you see with your own eyes :)

https://www.marketwatch.com/press-release/khiron-partners-with-colombia-cancer-league-to-deliver-3000-medical-cannabis-patient-consultations-2021-05-25

[Nosnibor]

Anyone attend this morning's conf call with Khiron Europe? The time difference didnt work for me unfortunately but would be interested to know any feedback from any investors here. TIA.

[jp68]

KHIRON TO HOST FIRST QUARTER 2021 CONFERENCE CALL ON MAY 28, 2021

https://money.tmx.com/en/quote/KHRNF:US/news/8185209314166475/Khiron_to_Host_First_Quarter_2021_Conference_Call_on_May_28_2021